Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma

This study has been completed.
Sponsor:
Collaborators:
Società Italiana Radiologia Medica SIRM
Treviso cà Foncello Hospital
University of Trieste
Azienda Ospedaliera Spedali Civili di Brescia
Pozzuoli Santa Maria delle Grazie Hospital
Azienda Ospedaliera Niguarda Cà Granda
University of Rome Tor Vergata
Information provided by (Responsible Party):
Stefano Colagrande, University of Florence
ClinicalTrials.gov Identifier:
NCT01411579
First received: August 5, 2011
Last updated: December 9, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2013
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)